Company Filing History:
Years Active: 2012-2020
Title: Annabell Francis Leske: Innovator in Predictive Biomarkers
Introduction
Annabell Francis Leske is a prominent inventor based in Allenby Gardens, Australia. She has made significant contributions to the field of medical research, particularly in the development of predictive biomarkers for cancer treatment. With a total of 4 patents to her name, her work is paving the way for advancements in patient care.
Latest Patents
Leske's latest patents focus on predictive biomarkers that are crucial for determining patient responses to vascular disrupting agents. One of her notable patents discusses biological markers such as SAP, SHBG, Myoglobin, MMP-9, and SCF, which are predictive for cancer patient responses to treatment. Another patent highlights baseline biomarkers, including Ferritin and IL-8, that serve a similar purpose in enhancing treatment efficacy for cancer patients.
Career Highlights
Annabell is currently associated with Bionomics Inc., where she continues to innovate and contribute to the medical field. Her research is instrumental in developing methods that improve treatment outcomes for cancer patients, showcasing her dedication to advancing healthcare.
Collaborations
Throughout her career, Annabell has collaborated with esteemed colleagues such as Gabriel Kremmidiotis and David Bibby. These partnerships have further enriched her research and expanded the impact of her work in the scientific community.
Conclusion
Annabell Francis Leske is a trailblazer in the realm of predictive biomarkers, with her innovative patents significantly influencing cancer treatment methodologies. Her ongoing work at Bionomics Inc. and collaborations with fellow researchers highlight her commitment to improving patient care through scientific advancements.